Kashani, A., & Schwartz, D. A. (2019). The Expanding Role of Anti–IL-12 and/or Anti–IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y).
Chicago ZitierstilKashani, Amir, und David A. Schwartz. "The Expanding Role of Anti–IL-12 And/or Anti–IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease." Gastroenterol Hepatol (N Y) 2019.
MLA ZitierstilKashani, Amir, und David A. Schwartz. "The Expanding Role of Anti–IL-12 And/or Anti–IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease." Gastroenterol Hepatol (N Y) 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.